Safety and efficacy of prophylaxis and on-demand treatment with BAY 94-9027: results of a phase 2/3 multicentre, partially randomized, open-label trial

被引：0
|
作者：
Reding, Mark [1 ]
Powell, Jerry [2 ]
Santagostino, Elena [3 ]
Ng, Heng Joo [4 ]
Lederman, Mel [5 ]
Wang, Maria [5 ]
Walsch, Rene [6 ]
Sax, Mirjam [7 ]
Michaels, Lisa A. [5 ]
机构：
[1] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA
[2] Univ Calif Davis, Sacramento, CA 95817 USA
[3] Maggiore Hosp Policlin, IRCCS Ca Granda Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[4] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[5] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[6] Bayer Vital GmbH, Leverkusen, Germany
[7] Bayer Pharma AG, Berlin, Germany
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial
    Konychev, Alexander
    Heep, Markus
    Moritz, Rose K. C.
    Kreuter, Alexander
    Shulutko, Alexander
    Fierlbeck, Gerhard
    Bouylout, Kamel
    Pathan, Rashidkhan
    Trostmann, Uwe
    Chaves, Ricardo L.
    DRUGS & AGING, 2013, 30 (10) : 829 - 836
  • [32] Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial
    Alexander Konychev
    Markus Heep
    Rose K. C. Moritz
    Alexander Kreuter
    Alexander Shulutko
    Gerhard Fierlbeck
    Kamel Bouylout
    Rashidkhan Pathan
    Uwe Trostmann
    Ricardo L. Chaves
    Drugs & Aging, 2013, 30 : 829 - 836
  • [33] Efficacy and safety of Cineole (Soledum®) in the treatment of patients with acute bronchitis: results of an open-label randomized clinical phase III study
    Peter Kardos
    Olga Khaletskaya
    Olga Kropova
    Clinical Phytoscience, 7 (1)
  • [34] A prospective, open-label, randomized, parallel study with AICC to evaluate the efficacy and safety of prophylactic vs. on-demand treatment in hemophilia A or B subjects with inhibitors
    Antunes, S.
    Tangada, S.
    Stasyshyn, O.
    Mamonov, V
    Phillips, J.
    Guzman-Becerra, N.
    Grigorian, A.
    Schroth, Ph
    Ewenstein, B. M.
    Wong, W. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 982 - 982
  • [35] Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial
    Sadahira, Takuya
    Wada, Koichiro
    Araki, Motoo
    Ishii, Ayano
    Takamoto, Atsushi
    Kobayashi, Yasuyuki
    Watanabe, Masami
    Watanabe, Toyohiko
    Nasu, Yasutomo
    Kumon, Hiromi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 529 - 534
  • [36] Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial
    Beck, L. A.
    Mette, D.
    Zhang, Q.
    Akinlade, B.
    Staudinger, H.
    Graham, N.
    Pirozzi, G.
    Ardeleanu, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S43 - S43
  • [37] A Randomized, Multicentre, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety Profile of Daming Capsule in Patients with Hypercholesterolemia
    Ai Jing
    Zhao Li-Mei
    Lu Yan-Jie
    Cai Ben-Zhi
    Zhang Yong
    Yang Bao-Feng
    PHYTOTHERAPY RESEARCH, 2009, 23 (07) : 1039 - 1042
  • [38] Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
    Kudo, Toshihiro
    Hamamoto, Yasuo
    Kato, Ken
    Ura, Takashi
    Kojima, Takashi
    Tsushima, Takahiro
    Hironaka, Shuichi
    Hara, Hiroki
    Satoh, Taroh
    Iwasa, Satoru
    Muro, Kei
    Yasui, Hirofumi
    Minashi, Keiko
    Yamaguchi, Kensei
    Ohtsu, Atsushi
    Doki, Yuichiro
    Kitagawa, Yuko
    LANCET ONCOLOGY, 2017, 18 (05): : 631 - 639
  • [39] Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Paiva da Silva Lima, Gabriel
    Cheng, Sunfa
    Mikol, Daniel D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (05) : 1716 - 1725
  • [40] Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
    Upadhyaya, Himanshu
    Chien, Jenny Y.
    Long, Amanda J.
    Bohm, Martin
    Kallewaard, Nicole
    Macpherson, Lisa
    Patel, Dipak
    Hufford, Matthew
    Krull, Constance
    Ang, Jocelyn
    Chen, Peter
    Muller, William
    Potts, Jeffrey
    Quinn, Timothy
    Williams, Mark
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (07) : 1861 - 1873
12345